Abstract:“Cultured meat” technologies aim to replace conventional meat with analogous or alternative bioproducts from animal cell culture. Developers of these technologies claim their products, also known as “cell-based” or “cultivated” meat, will be safer and more environmentally friendly than conventional meat while offering improved farm-animal welfare. To these ends, Open Philanthropy commissioned this assessment of cultured meat’s potential to measurably displace the consumption of conventional meat.Recognizing that the scalability of any cultured-meat products must in turn depend on the scale and process intensity of animal cell production, this study draws on techno-economic analysis and due-diligence perspectives in industrial fermentation and upstream biopharmaceuticals to assess the extent to which animal cell culture could be scaled like a fermentation process.The analysis identifies a number of significant barriers to the scale-up of animal cell culture. Bioreactor design principles indicate a variety of issues associated with bulk cell growth in culture: Low growth rate, metabolic inefficiency, catabolite and CO2 inhibition, and bubble-induced cell damage will all limit practical bioreactor volume and attainable cell density. With existing bioreactor designs and animal cell lines, a significant engineering effort would be required to address even one of these issues.Economic challenges are further examined. Equipment and facilities with adequate microbial contamination safeguards are expected to have high capital costs. Suitable formulations of amino acids and protein growth factors are not currently produced at scales consistent with food production, and their projected costs at scale are likewise high. The replacement of amino-acid media with plant protein hydrolysates is discussed and requires further study.Capital- and operating-cost analyses of conceptual cell-mass production facilities indicate production economics that would likely preclude the affordability of their products as food. The analysis concludes that metabolic efficiency enhancements and the development of low-cost media from plant hydrolysates are both necessary but insufficient conditions for the measurable displacement of conventional meat by cultured meat.

How biofabrication can accelerate cultured meat's path to market

Biofabrication's Contribution to the Evolution of Cultured Meat

Challenges and possibilities for bio-manufacturing cultured meat

Scale-Up Technologies for the Manufacture of Adherent Cells

Cell culture medium cycling in cultured meat: Key factors and potential strategies

Artificial Meat Industry: Production Methodology, Challenges, and Future

Large-scale cultured meat production: Trends, challenges and promising biomanufacturing technologies

Cultivated meat manufacturing: Technology, trends, and challenges

Scale-Up Economics for Cultured Meat: Techno-Economic Analysis and Due Diligence

Scale‐up economics for cultured meat

Towards resource-efficient and cost-efficient cultured meat

Sustainable Future Protein Foods: The Challenges and the Future of Cultivated Meat

Bioreactors, scaffolds and microcarriers and in vitro meat production—current obstacles and potential solutions

Bringing cultured meat to market: Technical, socio-political, and regulatory challenges in cellular agriculture

Scientific, sustainability and regulatory challenges of cultured meat

Scaffolds for the manufacture of cultured meat

Sculpting the future of meat: Biomaterial approaches and structural engineering for large‐scale cell‐based production

A review: analysis of technical challenges in cultured meat production and its commercialization

Cultured meat from stem cells: Challenges and prospects

Engineering Considerations on Large-Scale Cultured Meat Production

Tissue Engineering Challenges for Cultivated Meat to Meet the Real Demand of a Global Market